Recent Advances in Chronic Rhinosinusitis
A special issue of Sinusitis and Asthma (ISSN 2624-7003).
Deadline for manuscript submissions: closed (1 November 2019) | Viewed by 197
Special Issue Editor
Special Issue Information
Dear Colleagues,
CRS has been historically managed with topical steroid therapy and endoscopic sinus surgery. Chronic rhinosinusitis (CRS) remains an idiopathic chronic inflammatory disease that affects a significant proportion of the population. Treatment for CRS is multi-modal and typically includes long-term medical therapy(ies) and surgical intervention. New medical therapies for managing CRS and surgical techniques have been developed or are currently under evaluation. This Special Issue will explore and highlight new developments for the classification and management of CRS.
We welcome your proposed publication abstract with 3–6 explanatory sentences (max. 150 words) first. The final deadline for submitting the articles is 1 November 2019. All articles will be peer reviewed, and articles received before the deadline will be immediately processed. Please take note of the deadline.
Dr. Shaun Kilty
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Sinusitis and Asthma is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) is waived for well-prepared manuscripts submitted to this issue. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- rhinosinusitis
- chronic
- surgery
- biologic therapy
- antibiotics
- steroid
- bacteria
- microbiome
- probiotics
- treatment
